Navigation Links
Rusty worms in the brain
Date:3/5/2008

This release is available in German.

Iron is vital to human life; for example, it is a component of hemoglobin, the substance that makes our blood red and supplies our cells with oxygen. However, iron can also cause heavy damage; it is thought that iron deposits in the brain contribute to certain forms of neurodegenerative diseases such as Parkinsons, Huntington s, and Alzhiemers. A malfunction of the blood transporter transferrin may be to blame. A team led by Peter J. Sadler at the University of Warwick (Coventry, UK) and Sandeep Verma of the Indian Institute of Technology (Kanpur, India) has now been able to show that transferrin can clump together to form wormlike fibrils. As reported in the journal Angewandte Chemie, this process releases rustlike iron particles.

Within the body, iron is present in the form of iron ions with a threefold positive charge (Fe3+) and must always be well wrapped to prevent it from reacting with proteins and causing damage. In blood plasma, iron is carried in the pockets of the iron transport protein transferrin. It only gets unwrapped once it is inside special cellular organelles.

But things can go wrong in this system, as Sadler and his colleagues have now proven. The researchers deposited iron-loaded human transferrin onto various surfaces under conditions that emulate those in living organisms. By using microscopy and electron microscopy, the researchers showed that the proteins aggregate into long wormlike fibrils. These worms have a regular striped pattern; the narrow dark stripes contain something similar to rust. Within the fibrils, the iron ions are no longer properly enclosed; explains Sadler, instead, they aggregate into periodically arranged nanocrystals whose structure seems to be very similar to the iron oxide mineral lepidocrocite.

The researchers suspect that in certain forms of neurodegenerative disease, iron deposits may form in a similar fashion in the brain. Such iron crystals are highly reactive and could lead to the formation of toxic free radicals, which attack and destroy nerve cells. If this assumption can be verified in vivo, agents that hinder the aggregation of transferrin may be the foundation for a new family of drugs.


'/>"/>

Contact: Peter J. Sadler
p.j.sadler@warwick.ac.uk
44-247-652-3653
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. After more than 100 years apart, webworms devastate New Zealand parsnips
2. Snoozing worms help Penn researchers explain the evolution of sleep
3. Worms take the sniff test to reveal sex differences in brain
4. Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms
5. Scientists alter sexual orientation in worms
6. The myth of runners high revisited with brain imaging
7. Brains R Us: Neuroscience and education town hall
8. Advertisers, neuroscientists trace source of emotions in brain
9. Sex differences in the brains serotonin system
10. Book is the first high-resolution digital mouse brain atlas designed for Web applications
11. New MIT tool probes brain circuits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: